Misencik Tiffani sold $138K of CTEV
Misencik Tiffani (SVP, Chief Growth Officer) sold 5,812 shares of Claritev Corp (CTEV) at $23.81 ($0.14M total) on 2026-10-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest in size and unlikely to move the stock significantly, but it adds to the cumulative insider activity profile.
Market read
A routine insider sale with limited market impact; useful for compliance monitoring.
What to watch
Potential upcoming corporate actions or financing needs not disclosed.
Background
Form 4 filings provide transparent disclosure of insider transactions, useful for monitoring ownership changes.
Ticker impact
Officer Misencik Tiffani sold 5,812 shares for $138,390 via a 10b5-1 plan, reducing her stake to 107,917 shares.
likely slight downward pressure as the market prices the insider sale.
The transaction size is modest ($138k) and disclosed via a Form 4, indicating a routine sale rather than a material shift.
Market effects
Minimal impact on the broader biotech sector.
No significant regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale could be a routine liquidity event, not a negative signal.
Key entities
- OfficerMisencik Tiffani
SVP, Chief Growth Officer at Claritev Corp.
